Page 660 - Cardiac Nursing
P. 660

636    P AR T IV / Pathophysiology and Management of Heart Disease


            Nursing Care Plan 26-1           (continued)


                 NURSING INTERVENTIONS                           RATIONALE
                 1. Encourage family members to express feelings, and convey  1. Expression of concerns promotes effective coping.
                   understanding of their concerns and emotional stress.
                 2. Provide the family with honest information about the pa-  2–3. Fear is reduced by clarifying misunderstandings. Infor-
                   tient’s condition to reduce fears. Keep the family informed  mation decreases fear of the unknown.
                   of changes.
                 3. Set aside time during visiting hours to spend with the
                   family, and encourage family members to ask questions.
                   Offer explanations about the intensive care unit environ-
                   ment.
                 4. Encourage realistic hope based on the patient’s progress.  4. Hope helps the family with coping.
                   Point out progress to the family.
                 5. Allow family to participate in care as appropriate.  5. Participation decreases feelings of helplessness in aid-
                                                                    ing the recovery of the patient.
                 6. Determine how the family has coped with previous stress-  6. It is important to identify previous effective coping
                   ful situations.                                  mechanisms and to promote the use of these
                                                                    mechanisms.







           REFERENCES                                          14. Funk, M., Ford, C. F., Foell, D. W., et al. (1992). Frequency of long-term
                                                                 lower limb ischemia associated with intraaortic balloon pump use. The
            1. Maugh, T. H. (2007, December 7). Peter Houghton, 68. Los Angeles Times.  American Journal of Cardiology, 70, 1195.
            2. Rosamond, W., Flegal, K., Furie, K., et al. (2008). Heart disease and stroke  15. Barnett, M. G., Swartz, M. T., Peterson, G. J., et al. (1994). Vascular com-
              statistics—2008 update: A report from the American Heart Association  plications from intraaortic balloons: Risk analysis. Journal of Vascular
              Statistics Committee and Stroke Statistics Subcommittee. Circulation,  Surgery, 19, 81.
              117(4), e25–e146.                                16. Patel, J. J., Kopisyansky, C., Boston, B., et al. (1995). Prospective evalua-
            3. Deng, M. C., Young, J. B., Stevenson, L. W., et al. (2003). Destination  tion of complications with percutaneous intraaortic balloon counterpulsa-
              mechanical circulatory support: Proposal for clinical standards. The Jour-  tion. The American Journal of Cardiology, 76, 1205.
              nal of Heart and Lung Transplantation, 22(4), 365–369.  17. Cohen, M., Dawson, M. S., Kopistansky, C., et al. (2000). Sex and other
            4. Kantrowitz, A. (1990). Origins of intra-aortic balloon pumping. The   predictors of intra-aortic balloon counter pulsation-related complications:
              Annals of Thoracic Surgery, 50, 672–674.           Prospective study of 1119 consecutive patients. American Heart Journal,
            5. Mishra, S., Chu, W. W., Torguson, R., et al. (2006). Role of prophylactic  139, 282–287.
              intra-aortic balloon pump in high-risk patients undergoing percutaneous  18. Arafa, O. E., Pedersen, T. H., Svennevig, J. L., et al. (1999). Vascular com-
              coronary intervention. American Journal of Cardiology, 98, 608.  plications of the intra-aortic pump in patients undergoing open heart op-
            6. Brodie, B. R., Stuckey, T. D., Hansen, C., et al. (1999). Intra-aortic bal-  erations: 15 year experience. The Annals of Thoracic Surgery, 67, 645–651.
              loon counterpulsation before primary percutaneous transluminal coronary  19. Jiang, C. Y., Zhao, L. L., Wang, J. A., et al. (2003). Anticoagulation ther-
              angioplasty reduces catheterization laboratory events in high-risk patients  apy in intra-aortic balloon counterpulsation: Does IABP really need anti-
              with an acute myocardial infarction. American Journal of Cardiology, 84,  coagulation? Journal of Zhejiang University SCIENCE, 4, 607–611.
              18.                                              20. Gottlieb, S. O., Brinker, J. A., Borkon, A. M., et al. (1984). Identification
            7. Ferguson, J. J., Cohen, M., Freedman, R. J., et al. (2001). The current  of patients at high risk for complications of intraaortic balloon counter-
              practice of intra-aortic balloon counterpulsation: Results from the Bench-  pulsation: A multivariate risk factor analysis. The American Journal of Car-
              mark registry. Journal of the American College of Cardiology, 38, 1456.   diology, 53, 1135.
            8. Gitter, R., Cate, C. M., Smart, K., et al. (1998). Influence of ascending  21. Eltchaninoff, H., Dimas, A. P., Whitlow, P. L. (1993). Complications as-
              versus descending balloon counterpulsation on bypass graft blood flow.  sociated with percutaneous placement and use of intraaortic balloon coun-
              The Annals of Thoracic Surgery, 65, 365.           terpulsation. The American Journal of Cardiology, 71, 328.
            9. Mueller, H., Ayres, S. M., Conklin, E. F., et al. (1971). The effects of  22. Tatar, H., Cicek, S., Demirkilic, U., et al. (1993). Vascular complications
              intra-aortic counterpulsation on cardiac performance and metabolism  of intraaortic balloon pumping: Unsheathed versus sheathed insertion.
              shock associated with acute myocardial infarction. The Journal of Clinical  The Annals of Thoracic Surgery, 55, 1518.
              Investigation, 50, 1885.                         23. Scholz, K. H., Ragab, S., von zur Muhlen, F., et al. (1998). Complications of
           10. Scheidt, S., Wilner, G., Mueller, H., et al. (1973). Intraaortic balloon  intra-aortic balloon counterpulsation: The role of catheter size and duration
              counterpulsation in cardiogenic shock. The New England Journal of Med-  of support in a multivariate analysis of risk. European Heart Journal, 19, 458.
              icine, 288, 979.                                 24. Meharwal, Z. S., & Trehan, N. (2002). Vascular complications of intra-
           11. Kern, M. J., Aguirre, F. V., Tatineni, S., et al. (1993). Enhanced coronary  aortic balloon insertion in patients undergoing coronary revascularization:
              blood flow velocity during intraaortic balloon counterpulsation in criti-  Analysis of 911 cases. European Journal of Cardiothoracic, 21, 741.
              cally ill patients. Journal of the American College of Cardiology, 21, 359.  25. Erdogan, H. B., Goksedef, D., Erentug, V., et al. (2006). In which patients
           12. Urschel, C. W., Eber, L., Forrester, J., et al. (1970). Alteration of mechan-  should sheathless IABP be used? An analysis of vascular complications in
              ical performance of the ventricle by intraaortic balloon counterpulsation.  1211 cases. Journal of Cardiac Surgery, 21, 342.
              The American Journal of Cardiology, 25, 546.     26. Chen, E. W., Canto, J. G., Parsons, L. S., et al. (2003). Relation between
           13. McBride, L. R., Miller, L. W., & Nauheim, K. S. (1989). Axilliary artery  hospital intra-aortic balloon counterpulsation volume and mortality in
              insertion of an intra-aortic balloon pump. The Annals of Thoracic Surgery,  acute myocardial infarction complicated by cardiogenic shock. Circula-
              48, 874–875.                                       tion, 108, 951.
   655   656   657   658   659   660   661   662   663   664   665